Corcept Therapeutics, Inc. (CORT) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $113.38 -1.29%
EPS Growth %: +393.8%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +393.8%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $4.41 million versus the consensus estimate of $5.01 million.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
